Irene Ferrer
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 6
- Fibroblast Growth Factor Research 6
- Oncology 27
- Cancer-related Molecular Pathways 7
- Cancer Immunotherapy and Biomarkers 6
- Peptidase Inhibition and Analysis 5
- Co-authors
- Luis Paz‐Ares (36 shared papers)Jon Zugazagoitia (4 shared papers)Sonia Molina‐Pinelo (22 shared papers)Santiago Ponce (2 shared papers)Amancio Carnero (24 shared papers)Gerald Schmid‐Bindert (1 shared paper)William J. John (1 shared paper)Stephan Herbertz (1 shared paper)
- Journals
- Oncotarget (5 papers)Cancer Research (4 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)Clinical Lung Cancer (3 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Irene Ferrer
63 papers receiving 2.2k citations
Irene Ferrer's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 472
- Oncology 769
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 409
- Immunology 238
Countries citing papers authored by Irene Ferrer
This map shows the geographic impact of Irene Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Ferrer more than expected).
Fields of papers citing papers by Irene Ferrer
This network shows the impact of papers produced by Irene Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Ferrer. The network helps show where Irene Ferrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Irene Ferrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Current Challenges in Cancer Treatment Hit paper breakdown → | 2016 | 656 |
| 2 | 2018 | 229 | |
| 3 | 2012 | 153 | |
| 4 | 2013 | 71 | |
| 5 | 2014 | 66 | |
| 6 | 2013 | 59 | |
| 7 | 2008 | 57 | |
| 8 | 2007 | 54 | |
| 9 | 2019 | 51 | |
| 10 | 2019 | 45 | |
| 11 | 2008 | 42 | |
| 12 | 2019 | 42 | |
| 13 | 2020 | 40 | |
| 14 | 1995 | 40 | |
| 15 | 2009 | 38 | |
| 16 | 2016 | 37 | |
| 17 | 2007 | 34 | |
| 18 | 2008 | 32 | |
| 19 | 2015 | 29 | |
| 20 | 2016 | 27 |
About Irene Ferrer
Irene Ferrer is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 66 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Cancer-related Molecular Pathways (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (6 papers), Epigenetics and DNA Methylation (6 papers), Fibroblast Growth Factor Research (6 papers), Cancer Research and Treatments (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Cancer Research (472 citations), Oncology (769 citations), Molecular Biology (1.2k citations), Pulmonary and Respiratory Medicine (409 citations) and Immunology (238 citations). Irene Ferrer has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Luis Paz‐Ares, Jon Zugazagoitia, Sonia Molina‐Pinelo, Santiago Ponce, Amancio Carnero, Gerald Schmid‐Bindert, William J. John, Stephan Herbertz, Àlvaro Quintanal-Villalonga and Carmen Blanco‐Aparicio. Their work appears in journals such as Oncotarget, Cancer Research, Journal of Thoracic Oncology, Lung Cancer and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.